Showing Page:
1/7
APPLICATION GUIDELINES 1
Medical Application Critical Appraisal Guidelines
Chamberlain University College of Nursing
NR599-61907: Nursing Informatics for Advanced Practice
April 12, 2020
Showing Page:
2/7
APPLICATION GUIDELINES 2
Medical Application Critical Appraisal Guidelines
Medical applications are available to patients and providers to help navigate through
disease management and general information. Many applications are endorsed or affiliated with
various medical organizations, institutions of higher education, and government agencies. Some
of these applications are FDA approved. These applications are intended to be an aid in
understanding treatment, medications and general information as a resource to understanding
standardized treatment recommendations as set forth through these agencies. The following
application is used for reference in understanding AIDS management.
Name of Application
AIDSinfo Guidelines Mobile Application
Author of Application
National Institutes of Health (National Institutes of Health, 2020) published this
application which provides guidelines provided by the Department of Health and Human
Services (nih.gov, 2020). The goal is to allow easy access to patients, providers, and general
public on recommendations for treatment according to the U.S. Health and Human Services.
Endorsement of Application
AIDSinfo is funded by the Office of AIDS Research, National Institute of Allergy and
Infectious Diseases, Health Resources and Services Administration, and the Centers for Disease
Control and Prevention (nih.gov, 2020). AIDSinfo provides information on current treatments
including latest FDA clinical trials. These treatments are federally approved practice guidelines
(nih.gov, 2020).
Showing Page:
3/7
APPLICATION GUIDELINES 3
Operational Platform of Application
Both web-based and mobile platforms are available for AIDSinfo. The preference for the
smartphone app is more suitable as this is easily accessible on the user’s smartphone, and not
nearby a desktop computer or laptop now.
Aesthetics of Application
AIDSinfo is easy to navigate as tabs are relevant to what information the user seeks. The
user clicks or taps on a variety of tabs for answers to commonly asked questions. No instructions
are necessary as the application is easy to use and allows user to tap in and out of topics with
brief and full versions availability.
Purpose of Application
AIDSinfo intended use is for information on AIDS management, treatment, and a general
reference that is easily accessible to both patients and providers.
Use in Clinical Decision Making of Application
The influence of AIDSinfo allows for information at the user’s fingertips. Users are
given information in helping give information to obtain informed treatment decisions based on
CDC guidelines on the treatment for AIDS patient. The application provides federally approved
practice guidelines with full description of treatment regimens for adults, children and perinatal
(nih.gov, 2020).
Showing Page:
4/7
APPLICATION GUIDELINES 4
Application Safety
Safety and efficacy are of utmost importance within the application. There is various
safety guideline information related to drug treatments and trials, including reference safety
monitoring studies to reference. The application provides links to FDA approved guidelines, and
FDA safety guidelines regarding use of antiviral agents used in the treatment of AIDS (nih.gov,
2020). These guidelines are intended to notify user of potential risks of various treatment
modalities.
Privacy and Security of Application
In settings within the app there is PRIVACY POLICY TERMS tab. There is an
acknowledgment page that appears when app is downloaded or updated requesting acceptance of
privacy policy. The app clearly states within the privacy policy that information shared within
the app will not be shared with any organizations, agencies, nor social networks. Information
entered within app is kept personal on the user’s personal device and not shared. Privacy policy
terms states Google Analytics uses information about statistics on who uses app and what kinds
of devices access app. AIDSinfo does not collect personal information at risk of a privacy
breach.
Intended User for Application
The information provided by the app is intended for patients, researchers, and providers
to help the user gain a better understanding about AIDS, drug treatments, and clinical trial
guidelines.
Showing Page:
5/7
APPLICATION GUIDELINES 5
Distribution of Application
AIDSinfo is accessible to all who seek such guidelines and information. The AIDSinfo website
also offers alternative formats upon request.
Credibility of Application
This app gives information on federally approved medical practice guidelines for HIV
and AIDS. The National Institutes for Health maintains the information provided by AIDSinfo.
NIH is accessed globally billions of times a year (nih.gov, 2020). Credibility is backed by
various agencies including: Office of AIDS Research, National Institute of Allergy and
Infectious Disease, Health Resources and Services Administration and the Centers for Disease
Control and Prevention (nih.gov, 2020). According to NIH.gov (2020), the app also provides
FDA telephone reference for further information on HIV/AIDS clinical trials as mandated by the
Health Omnibus Programs Extension Act (HOPE).
Relevance of Application
New treatment modalities are updated regularly providing the most updated information
by the ACTIS and ATIS funded by public health agencies: NIH, CMS, CDC, and HRSA. The
site was last updated: April 12, 2020. The content within the app are evidence-based practice
guidelines based on standards of care for those with HIV/AIDS.
Clinical Scenario for AIDSinfo
Patient is a 23yo male transgender having multiple partners. He has history of heroin IV
drug use, admits last use yesterday at 6pm. Patient presents to ER with right hand cellulitis.
Showing Page:
6/7
APPLICATION GUIDELINES 6
Patient complains of redness, swelling, purulent drainage and pain at site lasting three days
before presenting to ER. Patient status is inpatient at present receiving IV antibiotic treatment for
cellulitis and referred to HIV/AIDS clinic for follow up care. Nurse will provide discharge
instructions including website for AIDSinfo and app download information. Patient is
encouraged to visit website prior to follow up care appointment and advised to write down
questions on disease process, treatment and prognosis for HIV/AIDS clinic. Providing patient
with discharge follow up instructions with detailed directions on how to access web site and
download app will help patient to participate in care and have information on disease, disease
process, and management will empower patient to make informed decisions on disease
management. Patient states he is ready to seek rehab for IV drug use and “kick the habit”.
Conclusion
The use of applications is a useful tool for patients and providers alike in making
decisions concerning the treatment of diseases providing informed consent. The use of such
apps allows the patient to be proactive and a participant in the care of their disease processes.
This provides a positive impact on patient outcomes and compliance with various treatment
modalities.
Showing Page:
7/7
APPLICATION GUIDELINES 7
References
National Institute of Health. (2020). AIDSinfo: Privacy policy for the AIDSinfo Guidelines
mobile application. Retrieved from https://aidsinfo.nih.gov/

Unformatted Attachment Preview

APPLICATION GUIDELINES 1 Medical Application Critical Appraisal Guidelines Chamberlain University College of Nursing NR599-61907: Nursing Informatics for Advanced Practice April 12, 2020 APPLICATION GUIDELINES 2 Medical Application Critical Appraisal Guidelines Medical applications are available to patients and providers to help navigate through disease management and general information. Many applications are endorsed or affiliated with various medical organizations, institutions of higher education, and government agencies. Some of these applications are FDA approved. These applications are intended to be an aid in understanding treatment, medications and general information as a resource to understanding standardized treatment recommendations as set forth through these agencies. The following application is used for reference in understanding AIDS management. Name of Application AIDSinfo Guidelines Mobile Application Author of Application National Institutes of Health (National Institutes of Health, 2020) published this application which provides guidelines provided by the Department of Health and Human Services (nih.gov, 2020). The goal is to allow easy access to patients, providers, and general public on recommendations for treatment according to the U.S. Health and Human Services. Endorsement of Application AIDSinfo is funded by the Office of AIDS Research, National Institute of Allergy and Infectious Diseases, Health Resources and Services Administration, and the Centers for Disease Control and Prevention (nih.gov, 2020). AIDSinfo provides information on current treatments including latest FDA clinical trials. These treatments are federally approved practice guidelines (nih.gov, 2020). APPLICATION GUIDELINES 3 Operational Platform of Application Both web-based and mobile platforms are available for AIDSinfo. The preference for the smartphone app is more suitable as this is easily accessible on the user’s smartphone, and not nearby a desktop computer or laptop now. Aesthetics of Application AIDSinfo is easy to navigate as tabs are relevant to what information the user seeks. The user clicks or taps on a variety of tabs for answers to commonly asked questions. No instructions are necessary as the application is easy to use and allows user to tap in and out of topics with brief and full versions availability. Purpose of Application AIDSinfo intended use is for information on AIDS management, treatment, and a general reference that is easily accessible to both patients and providers. Use in Clinical Decision Making of Application The influence of AIDSinfo allows for information at the user’s fingertips. Users are given information in helping give information to obtain informed treatment decisions based on CDC guidelines on the treatment for AIDS patient. The application provides federally approved practice guidelines with full description of treatment regimens for adults, children and perinatal (nih.gov, 2020). APPLICATION GUIDELINES 4 Application Safety Safety and efficacy are of utmost importance within the application. There is various safety guideline information related to drug treatments and trials, including reference safety monitoring studies to reference. The application provides links to FDA approved guidelines, and FDA safety guidelines regarding use of antiviral agents used in the treatment of AIDS (nih.gov, 2020). These guidelines are intended to notify user of potential risks of various treatment modalities. Privacy and Security of Application In settings within the app there is PRIVACY POLICY TERMS tab. There is an acknowledgment page that appears when app is downloaded or updated requesting acceptance of privacy policy. The app clearly states within the privacy policy that information shared within the app will not be shared with any organizations, agencies, nor social networks. Information entered within app is kept personal on the user’s personal device and not shared. Privacy policy terms states Google Analytics uses information about statistics on who uses app and what kinds of devices access app. AIDSinfo does not collect personal information at risk of a privacy breach. Intended User for Application The information provided by the app is intended for patients, researchers, and providers to help the user gain a better understanding about AIDS, drug treatments, and clinical trial guidelines. APPLICATION GUIDELINES 5 Distribution of Application AIDSinfo is accessible to all who seek such guidelines and information. The AIDSinfo website also offers alternative formats upon request. Credibility of Application This app gives information on federally approved medical practice guidelines for HIV and AIDS. The National Institutes for Health maintains the information provided by AIDSinfo. NIH is accessed globally billions of times a year (nih.gov, 2020). Credibility is backed by various agencies including: Office of AIDS Research, National Institute of Allergy and Infectious Disease, Health Resources and Services Administration and the Centers for Disease Control and Prevention (nih.gov, 2020). According to NIH.gov (2020), the app also provides FDA telephone reference for further information on HIV/AIDS clinical trials as mandated by the Health Omnibus Programs Extension Act (HOPE). Relevance of Application New treatment modalities are updated regularly providing the most updated information by the ACTIS and ATIS funded by public health agencies: NIH, CMS, CDC, and HRSA. The site was last updated: April 12, 2020. The content within the app are evidence-based practice guidelines based on standards of care for those with HIV/AIDS. Clinical Scenario for AIDSinfo Patient is a 23yo male transgender having multiple partners. He has history of heroin IV drug use, admits last use yesterday at 6pm. Patient presents to ER with right hand cellulitis. APPLICATION GUIDELINES 6 Patient complains of redness, swelling, purulent drainage and pain at site lasting three days before presenting to ER. Patient status is inpatient at present receiving IV antibiotic treatment for cellulitis and referred to HIV/AIDS clinic for follow up care. Nurse will provide discharge instructions including website for AIDSinfo and app download information. Patient is encouraged to visit website prior to follow up care appointment and advised to write down questions on disease process, treatment and prognosis for HIV/AIDS clinic. Providing patient with discharge follow up instructions with detailed directions on how to access web site and download app will help patient to participate in care and have information on disease, disease process, and management will empower patient to make informed decisions on disease management. Patient states he is ready to seek rehab for IV drug use and “kick the habit”. Conclusion The use of applications is a useful tool for patients and providers alike in making decisions concerning the treatment of diseases providing informed consent. The use of such apps allows the patient to be proactive and a participant in the care of their disease processes. This provides a positive impact on patient outcomes and compliance with various treatment modalities. APPLICATION GUIDELINES 7 References National Institute of Health. (2020). AIDSinfo: Privacy policy for the AIDSinfo Guidelines mobile application. Retrieved from https://aidsinfo.nih.gov/ Name: Description: ...
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.
Studypool
4.7
Trustpilot
4.5
Sitejabber
4.4